Alpha Capital Partners

Nanofabrica, founded in 2016 and based in Tel Aviv, Israel, specializes in 3D printing technology for precision manufacturing, targeting sectors such as semiconductors, optics, and medical devices. The company focuses on micro and nano-scale manufacturing, leveraging its patent-pending technology to enable the mass customization of intricate parts at competitive prices. By collaborating closely with customers, Nanofabrica continually refines its offerings to meet the demands of emerging markets, including robotics and biomedical applications. The company aims to transform complex design concepts into reality, facilitating innovative solutions across various industries.

Diagnostic Robotic develops a signal-agnostic artificial intelligence system for healthcare insurers, providers, and patients. It allows to build powerful predictive analytics models that will solve a world-wide challenge, strained health budgets, and workforces. Diagnostic Robotic was founded on 2017 and is headquartered in Tel Aviv, Israel.

Shree is based on the idea that you should never go out of vogue. Providing fast-fashion Indian wear along with unmatched value for the new age women, Shree has swiftly become one of the top seller brands on all the leading ecommerce stores like Snapdeal, Myntra, Jabong, Flipkart, Fashion and You, eBay, Homeshop18, Limeroad, India Emporium and more. We have 25 + exclusive Brand outlets in Delhi NCR, Telangana, Surat, Hissar and Uttarkhand. Our strong network of dealers and distributors, wholesalers and retailers, MBO’s in various states facilitate Shree to showcase products in 2000+ stores.

InCred Financial Services Limited is a non-banking financial corporation based in Mumbai, India, that provides a range of loan products to retail, small and medium enterprises (SMEs), and commercial customers. The company operates primarily through two segments: Consumer Retail and SME, offering personal, education, business, and two-wheeler loans, as well as affordable home loans. Leveraging technology and data science, InCred aims to simplify the lending process, making it quick and hassle-free for its clients. Originally known as Visu Leasing and Finance Private Limited, InCred was incorporated in 1991 and is a subsidiary of Bee Finance Limited based in Mauritius.

In the year 1956, the foundation of brand Hero was laid by Late Mr. Dayanand Munjal with a vision of providing mobility to millions in India. In the following years, the brand expanded itself enormously in varied fields like Bicycles, Motorcycles, Healthcare, etc. and became the most renowned & trusted name worldwide.

CredAble combines technology, financing, deep learning, and analytics to create innovative supply chain financing products dynamically.

Founded in April 2015, BaishanCloud(BSC) is a provider of cloud managed services, specializing in cloud resource exchanges and interactions. With a strong emphasis on data governance, BSC’s cloud managed product suite is comprised of three major services – cloud delivery, cloud storage and cloud linkages. BSC was the first company to introduce the CCX concept– Cloud Connects Everything – to the China market. Leveraging its robust and loosely coupled cloud delivery and cloud storage network, BSC provides a cloud management platform to fulfill the data-migration and data-integration needs of enterprise customers. The platform provides data storage, data integration, data acceleration, and data analytics services.

Just Buy Live is a proficient, large scale E-Distributor in the New Commerce / Mobile Retail space. It has at the heart of its ecosystem - the Empowerment of Retailers. Supplying goods directly from Brands to Retailers (B2R). Just Buy Live has access to a very wide range of Brands with simplified technology that enhances the buying experience which is inclusive of Financial Services.

Friendable, Inc. is a mobile-focused technology and marketing company based in Campbell, California, specializing in online dating and social networking applications. Established in 2007, the company offers its flagship application, Friendable, which enables users to arrange one-on-one or group meetups. Additionally, Friendable provides Fan Pass, a mobile platform designed to connect fans with their favorite celebrities and artists. The company emphasizes proximity-based features that facilitate social interactions among users. Originally known as iHookup Social, Inc., it rebranded to Friendable, Inc. in September 2015.

LiveIntent is a marketing technology platform that specializes in enhancing email as a powerful tool for identity resolution and targeted marketing. Serving over 2,000 brands and publishers worldwide, LiveIntent transforms traditional email communication into a robust mechanism for customer engagement and revenue generation in a mobile-first environment. The platform creates a private customer graph that supports various marketing objectives, including acquisition and attribution. Headquartered in New York City, LiveIntent has additional offices in cities such as Berlin, Chicago, and Los Angeles, employing around 170 people. Its full-service email advertising solutions cater to the needs of both marketers and publishers, positioning the company as a leader in the email marketing landscape.

VeriTeQ is a technology company focused on animal and emergency identification solutions. Its products are utilized around the world in such applications as pet identification using its patented, FDA-approved implantable microchip; livestock identification and tracking using visual and radio frequency identification (RFID) ear tags; and global positioning systems (GPS) search and rescue beacons for use on aircraft, ships and boats, and by adventure enthusiasts. The company was founded in 1993 and headquartered in Delray Beach, Florida.

CEL-SCI Corporation, founded in 1983 and headquartered in Vienna, Virginia, focuses on the research and development of immunotherapy products to treat cancer and infectious diseases. The company's leading investigational therapy, Multikine, is currently undergoing phase III clinical trials for head and neck cancer. Additionally, CEL-SCI has developed a patented T-cell modulation process known as the Ligand Epitope Antigen Presentation System (LEAPS), which aims to enhance the immune response against a range of health issues, including bacterial, viral, and parasitic infections, as well as autoimmune diseases and allergies. The company is also working on LEAPS-H1N1-DC, CEL-2000, and CEL-4000 for rheumatoid arthritis, alongside LEAPS COV-19 to address COVID-19. CEL-SCI has partnered with the University of Georgia’s Center for Vaccines and Immunology to advance its COVID-19 immunotherapy initiatives.

Aprecia Pharmaceuticals, LLC is a pharmaceutical company specializing in the development and manufacture of innovative drug delivery systems. Founded in 2003 and headquartered in Blue Ash, Ohio, the company focuses on advanced technologies such as ZipDose, which provides orodispersible formulations that combine high-dose capabilities with taste-masking options. Aprecia's product portfolio includes SPRITAM, a medication for treating various types of seizures, and CustomRelease, which offers tailored time release profiles for medications. The company also develops NanoDose for submilligram dosing and ImplantaDose for post-surgical management of infections and pain. Aprecia's commitment to transforming patient and caregiver experiences is evident in its use of three-dimensional printing technology to create fast-melt pharmaceutical products. The company's manufacturing facilities are located in East Windsor and New Jersey.

Somanta Pharmaceuticals a development stage biopharmaceutical company, develops drugs primarily for the treatment of cancer. It holds a license to develop Sodium Phenylbutyrate for the treatment of cancer, autoimmune diseases, and other clinical indications. The company's products in the pre-clinical stage of development include Alchemix, which is intended to interrupt various phases of the cancer cell growth cycle by selectively binding to DNA and inhibiting DNA processing enzymes to overcome drug resistant tumors.